Filing Flows › Palatin Technologies (PTN) › Recalls, complaints & regulation
Palatin Technologies (PTN): clinical trials
Palatin Technologies (PTN) beyond its filings: 2 active clinical trials.
Palatin Technologies' latest quarter
Palatin Technologies, Q4 FY26: revenue $301K, net loss $4.4M, operating cash flow −$2.7M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Palatin Technologies have?
2 active studies on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.